clinical trial · NCT06629103
A Study in Healthy Subjects to Compare the Bioavailability of EPA + DHA
RDC Clinical Pty Ltd·phase4·active not recruiting·n = 120
Optimal Absorption of Omega-3Healthylife's Omega 1035DSFish OilPlacebolife's Omega O3020DS
brief summary
This is a randomised, double-blind, parallel, placebo-controlled study in healthy subjects to compare the absorption of two microalgal formulations, to a fish oil and a placebo.
started
Aug 6, 2025
primary completion
Dec 1, 2026
completion
Dec 1, 2026
last updated
Nov 18, 2025
official title
A Randomized, Double-blind Placebo-controlled Study in Healthy Subjects to Compare the Bioavailability of EPA + DHA From Two Microalgal Sources to One Fish Source
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol